Association between P16INK4a Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Gu, Jundong ^a,b   Wen, Yanjun ^a   Zhu, Siwei ^b   Hua, Feng ^c   Zhao, Hui ^b   Xu, Hongrui ^b   You, Jiacong ^a   Sun, Linlin ^a   Wang, Weiqiang ^a   Chen, Jun ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN UNION MEDICAL CENTER   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; CANCER TISSUE; DNA METHYLATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; P16INK4A GENE; PROMOTER REGION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REGRESSION ANALYSIS;

EID: 84875925314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060107     Document Type: Article

References (51)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61(2): 69-90.
2. Risch A, Plass C, (2008) Lung cancer epigenetics and genetics. Int J Cancer 123(1): 1-7.
3. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, et al. (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346(2): 92-98.
4. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, et al. (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and apotential biomarker for early diagnosis. Proc Natl Acad Sci U S A 95(20): 11891-11896.
5. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB, (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93(18): 9821-9826.
6. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, et al. (2001) Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61(1): 249-255.
7. Zhang CY, Jin YT, Xu HY, Zhang H, Zhang WM, et al. (2011) Relationship between promoter methylation of p16, DAPK and RAR beta genes andthe clinical data of non-small cell lung cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 28(1): 23-28.
8. Wang Y, Zhang D, Zheng W, Luo J, Bai Y, et al. (2008) Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Cancer 112(6): 1325-1336.
9. Higgins JP, Green S (2008) Cochrane Handbook for Systematic Reviews of Interventions updated March 2011 John Wiley & Sons, Available: http://www.cochrane-handbook.org/.Accessed: 2011 DEC 12.
10. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3): 177-188.
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414): 557-560.
12. Egger M, Davey SG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109): 629-634.
13. Seike M, Gemma A, Hosoya Y, Hemmi S, Taniguchi Y, et al. (2000) Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Clin Cancer Res 6(11): 4307-4313.
14. Liu JY, An Q, Xu GD, Lei WD, Li L, et al. (2004) Hypermethylation of p16 gene in clinical specimens of patients with lung cancer. Zhonghua Zhong Liu Za Zhi 26(2): 75-77.
15. Ulivi P, Zoli W, Calistri D, Fabbri F, Tesei A, et al. (2006) P16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients. J Cell Physiol 206(3): 611-6115.
16. Su C, Ye Y, Wang D, (2000) Correlation between methylation on SmaI locus of the CDKN2/p16 gene CpG island and lung cancer. Zhonghua Zhong Liu Za Zhi 22(6): 471-473.
17. Ng CS, Zhang J, Wan S, Lee TW, Arifi AA, et al. (2002) Tumor p16M is a possible marker of advanced stage in non-small cell lung cancer. J Surg Oncol 79(2): 101-106.
18. Liu Y, An Q, Li L, Zhang D, Huang J, et al. (2003) Hypermethylation of p16INK4a in Chinese lung cancer patients: biological andclinical implications. Carcinogenesis 24(12): 1897-1901.
19. Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, et al. (2005) Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 11(7): 2466-2470.
20. Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, et al. (2007) Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer 96(8): 1278-1283.
21. Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, et al. (2007) Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 110(9): 2019-2026.
22. Hong YS, Roh MS, Kim NY, Lee HJ, Kim HK, et al. (2007) Hypermethylation of p16INK4a in Korean non-small cell lung cancer patients. J Korean Med Sci 22 (Suppl):: S32-37.
23. Georgiou E, Valeri R, Tzimagiorgis G, Anzel J, Krikelis D, et al. (2007) Aberrant p16 promoter methylation among Greek lung cancer patients and smokers:correlation with smoking. Eur J Cancer Prev 16(5): 396-402.
24. Hsu HS, Chen TP, Wen CK, Hung CH, Chen CY, et al. (2007) Multiple genetic and epigenetic biomarkers for lung cancer detection incytologically negative sputum and a nested case-control study for risk assessment. J Pathol 213(4): 412-419.
25. Chen JT, Chen YC, Wang YC, Tseng RC, Chen CY, et al. (2002) Alterations of the p16(ink4a) gene in resected nonsmall cell lung tumors and exfoliated cells within sputum. Int J Cancer 98(5): 724-731.
26. Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, et al. (2003) Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancerpatients. Clin Cancer Res 9(4): 1370-1375.
27. Guo M, House MG, Hooker C, Han Y, Heath E, et al. (2004) Promoter hypermethylation of resected bronchial margins: a field defect ofchanges. Clin Cancer Res 10(15): 5131-5136.
28. Kim DS, Cha SI, Lee JH, Lee YM, Choi JE, et al. (2007) Aberrant DNA methylation profiles of non-small cell lung cancers in a Koreanpopulation. Lung Cancer 58(1): 1-6.
29. Cirincione R, Lintas C, Conte D, Mariani L, Roz L, et al. (2006) Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study. Int J Cancer 118(5): 1248-1253.
30. Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, et al. (2002) P16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR inplasmas from non-small cell lung cancer. Clin Cancer Res 8(12): 3782-3787.
31. He JY, WJ, Zhou Y, Liang B, Wang ZG, (2011) Aberrant methylation of 5'CpG island in the p16 tumor suppressor gene in non-small cell lung cancer. Journal of Guangdong Medical College 35(3): 321-322.
32. He Y, Zhang SL, Yang LP, Li SJ, Tang BX, (2002) Aberrent methylation of p16(INK4A) in non-small cell lung cancer. Chinese Journal of Health Laboratory Technology 12(3): 294-295.
33. Cai ZX, Liang QZ, Liao SX, Zhang XX, Wang X, (2003) Detection of Methylation in p16 Gene Promoter in Serum of Non-small Cell Lung Cancer. China Cancer 12(9): 536-538.
34. Zhang W, Sun YE, Cai Q, Wang GH, Lu GM, (2004) The study of p16 methylation and p16 protein expression in non-small cell lung cancers(NSCLC). Medical Journal of Air Force 20(1): 25-30.
35. Li WF, Xu H, Zhang L, (2006) Aberrant methylation of p16 gene in plasma of patients with non-small cell lung cancer. Journal of Guangdong Medical College 27(6): 855-856.
36. Wang YS, Jin YT, Xue SL, Yu ZC, Xu YC, et al. (2006) Research on methylation of p16 gene in non-small cell lung cancer. Acta Universitatis Medicinalis Anhui 41(6): 619-621.
37. Yang ZH, Cai YY, Sun LH, Qiao Y, (2007) Aberrant promoter methylation of p16(INK4A) and RASSF1A genes in non-small cell lung cancers. Journal of Practical Oncology 22(2): 153-155.
38. Zhang L, (2007) A preliminary study of radiotherapeutic target region design for NSCLC by detection of p16 gene methylation. Med J Qilu 22(4): 347-349.
39. Guo X J, Shen L, Zhang H, Wang Y, (2008) The detection and clinical diagnostic value of promoter hypermethylation of p16 gene in serum and tissue of lung cancer patients. Hebei Medical Journal 30(6): 757-759.
40. Chen SH, Xue SL, Jin YT, Yu ZC, Hu HL, et al. (2010) Methylation of p16 gene in plasma and tissues from non-small cell lung cancer patients. Chin J Lab Diagn 14(7): 1035-1038.
41. Guo MF, Liu H, Feng L, Wang YC, (2010) Methylation of p16 gene in lung cancer patients. MMJC12(5): 82-83.
42. Zhang ZX, Zhang L, (2006) Methylation of ASC and p16 genes in promoter region associated with genesis and progress of non-small cell lung cancer. China Journal of Modern Medicine 16(9): 1338-44.
43. Sun N, Zhang L, Liu YY, Zheng SY, Zhao X, (2012) Methylation of P16 and RASSF1A Genes in Sputum Samples Associated with Peripheral Non-Small Cell Lung Cancer. Progress in Modern Biomedicine 12(13): 2503-2510.
44. Liggett WH, Sidransky D, (1998) Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16(3): 1197-1206.
45. Brambilla E, Moro D, Gazzeri S, Brambilla C, (1999) Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. J Pathol 188(4): 351-360.
46. Gazzeri S, Gouyer V, Vour'ch C, Brambilla C, Brambilla E, (1998) Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene 16(4): 497-504.
47. Zhang B, Zhu W, Yang P, Liu T, Jiang M, et al. (2011) Cigarette smoking and p16INK4alpha gene promoter hypermethylation in non-smallcell lung carcinoma patients: a meta-analysis. PLOS ONE 6(12): e28882.
48. Esteller M, (2008) Epigenetics in cancer. N Engl J Med 358(11): 1148-1159.
49. Trinquart L, Abbe A, Ravaud P, (2012) Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials. PLOS ONE 7(4): e35219.
50. Taby R, Issa JP, (2010) Cancer epigenetics. CA Cancer J Clin 60(6): 376-392.
51. Sapari NS, Loh M, Vaithilingam A, Soong R, (2012) Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLOS ONE 7(4): e36275.